JP2025507851A5 - - Google Patents
Info
- Publication number
- JP2025507851A5 JP2025507851A5 JP2024551974A JP2024551974A JP2025507851A5 JP 2025507851 A5 JP2025507851 A5 JP 2025507851A5 JP 2024551974 A JP2024551974 A JP 2024551974A JP 2024551974 A JP2024551974 A JP 2024551974A JP 2025507851 A5 JP2025507851 A5 JP 2025507851A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- substituted
- item
- unsubstituted
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263315472P | 2022-03-01 | 2022-03-01 | |
| US63/315,472 | 2022-03-01 | ||
| US202263327345P | 2022-04-04 | 2022-04-04 | |
| US63/327,345 | 2022-04-04 | ||
| PCT/US2023/063521 WO2023168296A2 (en) | 2022-03-01 | 2023-03-01 | Cb1 ligand conjugated compounds and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507851A JP2025507851A (ja) | 2025-03-21 |
| JP2025507851A5 true JP2025507851A5 (cg-RX-API-DMAC10.html) | 2026-03-06 |
Family
ID=87884350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024551974A Pending JP2025507851A (ja) | 2022-03-01 | 2023-03-01 | Cb1リガンドコンジュゲート化合物及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20260174876A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4486336A2 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025507851A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240167826A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119136797A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023227871A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3253953A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL315177A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024010709A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023168296A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4698652A2 (en) * | 2023-04-20 | 2026-02-25 | Adarx Pharmaceuticals, Inc. | Mapt-modulating compositions and methods of use thereof |
| CN120647684A (zh) * | 2024-03-13 | 2025-09-16 | 清华大学 | 含有生育酚结构的辅助脂质分子、包含其的脂质纳米颗粒及其用途 |
| CN120208906B (zh) * | 2024-11-21 | 2025-10-28 | 广州同隽医药科技有限公司 | 维生素e衍生物、其载体化合物及其应用 |
-
2023
- 2023-03-01 AU AU2023227871A patent/AU2023227871A1/en active Pending
- 2023-03-01 KR KR1020247032182A patent/KR20240167826A/ko active Pending
- 2023-03-01 US US18/842,673 patent/US20260174876A1/en active Pending
- 2023-03-01 CA CA3253953A patent/CA3253953A1/en active Pending
- 2023-03-01 JP JP2024551974A patent/JP2025507851A/ja active Pending
- 2023-03-01 CN CN202380037352.1A patent/CN119136797A/zh active Pending
- 2023-03-01 EP EP23764099.0A patent/EP4486336A2/en active Pending
- 2023-03-01 IL IL315177A patent/IL315177A/en unknown
- 2023-03-01 WO PCT/US2023/063521 patent/WO2023168296A2/en not_active Ceased
-
2024
- 2024-08-30 MX MX2024010709A patent/MX2024010709A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104640540B (zh) | 与抗炎活性偶联的增强的抗流感剂 | |
| US9968618B1 (en) | Combination therapies for the treatment of Alzheimer's disease and related disorders | |
| ES2244733T3 (es) | Derivados de n-adamantilalquil-benzamida como antagonistas del receptor p2x7. | |
| JP2022505234A5 (cg-RX-API-DMAC10.html) | ||
| JP2021534124A5 (cg-RX-API-DMAC10.html) | ||
| JP7331843B2 (ja) | Btk阻害活性を有する化合物を有効成分として含む自己免疫疾患の予防および/または治療剤 | |
| JP2009544618A5 (cg-RX-API-DMAC10.html) | ||
| JP2021105002A5 (cg-RX-API-DMAC10.html) | ||
| JP7204780B2 (ja) | 老化細胞によって引き起こされるかまたは媒介される状態の臨床管理における使用のためおよびがんを治療するための、Bclファミリーアンタゴニストであるアシルホスホノアミダートおよびアシルベンジルアミン | |
| JP6270848B2 (ja) | ベータ−クロロシクロペンタンの親水性エステルプロドラッグの使用による角膜中央部肥厚の低下 | |
| JP2025506186A5 (cg-RX-API-DMAC10.html) | ||
| JPH09512804A (ja) | 5−ht1dアンタゴニストとして有用なビフェニルカルボキシアミド類 | |
| US20240100172A1 (en) | Methods and compounds for targeted autophagy | |
| JP2019530674A5 (cg-RX-API-DMAC10.html) | ||
| CN119136797A (zh) | Cb1配体缀合的化合物及其用途 | |
| JP2024041835A (ja) | 置換テトラヒドロシクロペンタ[c]ピロール、置換ジヒドロピロリジン、その類似体、およびそれらを使用する方法 | |
| JP2007530549A (ja) | ピラゾール化合物およびそれに関連する使用 | |
| US7235584B2 (en) | Non-psychotropic cannabinoids | |
| EP3484864A1 (en) | Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines | |
| JP2021512898A5 (cg-RX-API-DMAC10.html) | ||
| NL1030405C2 (nl) | L-tartraatzout van N-1-adamantyl-2-{3-[(2R)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxy- methyl)fenyl)ethyl}amino)propyl)fenyl}aceetamide. | |
| JP2024543187A5 (cg-RX-API-DMAC10.html) | ||
| RU2732417C1 (ru) | Производные фенотиазина и способы их применения | |
| TW202330489A (zh) | 稠合環類化合物、其製備方法及其在醫藥上的應用 | |
| JP2001505213A (ja) | 置換ベンズアミド誘導体および該化合物を含有する医薬組成物 |